Low Density Contrast Media Market

Contrast agents, also called contrast media, are substances used to enhance the radiodensity of a targeted tissue by altering the way that electromagnetic radiation or ultrasound waves pass through the body. These substances can be administered to the patient orally, rectally, or intravenously.

Low Density Contrast Media Market contains market size and forecasts of Low Density Contrast Media in global, including the following market information:

• Global Low Density Contrast Media Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Low Density Contrast Media Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Low Density Contrast Media companies in 2021 (%)

The global Low Density Contrast Media market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Iodine Based Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Low Density Contrast Media include Jiangsu Hengrui Medicine Co.,Ltd., Yangtze River Pharmaceutical (Group) Co., Ltd., Ge Healthcare Shanghai Co., Ltd., BAYER, Shanghai Bracco Sine Pharmaceutical Co., Ltd., Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd., Beijing Beilu Pharmaceutical Co.,Ltd., Starry Pharmaceutical and Guerbet. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Low Density Contrast Media manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Low Density Contrast Media Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Low Density Contrast Media Market Segment Percentages, by Type, 2021 (%)

• Iodine Based
• Barium Sulfate Compounds

Global Low Density Contrast Media Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Low Density Contrast Media Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Other

Global Low Density Contrast Media Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Low Density Contrast Media Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Low Density Contrast Media revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Low Density Contrast Media revenues share in global market, 2021 (%)
• Key companies Low Density Contrast Media sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Low Density Contrast Media sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Jiangsu Hengrui Medicine Co.,Ltd.
• Yangtze River Pharmaceutical (Group) Co., Ltd.
• Ge Healthcare Shanghai Co., Ltd.
• BAYER
• Shanghai Bracco Sine Pharmaceutical Co., Ltd.
• Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd.
• Beijing Beilu Pharmaceutical Co.,Ltd.
• Starry Pharmaceutical
• Guerbet